We're sorry, but we're unable to process your login. Please try again.
We're sorry, you are not authorized to access this site. Please contact your local Merck representative if you have any inquiries.
This page requires you to register for an account with Merck. Please login with your Merck account credentials below, or register for a new account.

Log in with Merck
{* #signInForm *}
{* signInEmailAddress *}
{* currentPassword *}
{* captcha *}
{* /signInForm *}

GGI 2016

The 2016 recipients of the GGI were announced on Sunday, September 11, 2016, coinciding with the 55th ESPE meeting in Paris, France.


The winners of the 2016 GGI were:

Andrew J. Brooks, PhD University of Queensland Diamantina Institute, Brisbane, Australia

Targeting the transmembrane domain of the growth hormone receptor to develop new drug classes addressing unmet needs in treatment of growth hormone disorders

Antonio Cittadini, MD Federico II University, Naples, Italy

Treatment of growth hormone deficiency associated with chronic heart failure: A randomized, double-blind, placebo-controlled study

Alexander Augusto de Lima Jorge, MD, PhD University of São Paulo Medical School, Brazil

Growth hormone and estrogen pharmacogenetics in patients with Turner syndrome

Leaving website.

You are leaving our website. This link will take you to a website to which our Privacy Policy and Conditions may not apply. Merck has no control over the contents and policies of third party sites or resources, and accepts no responsibility for them or for any loss or damage that may arise from your use of them. Please check Privacy Policy and Conditions of the linked website.